Literature DB >> 19144982

The MLL recombinome of adult CD10-negative B-cell precursor acute lymphoblastic leukemia: results from the GMALL study group.

Thomas Burmeister1, Claus Meyer, Stefan Schwartz, Julia Hofmann, Mara Molkentin, Eric Kowarz, Björn Schneider, Thorsten Raff, Richard Reinhardt, Nicola Gökbuget, Dieter Hoelzer, Eckhard Thiel, Rolf Marschalek.   

Abstract

MLL translocations in adult B-cell precursor (BCP) acute lymphoblastic leukemia (ALL) are largely restricted to the immature CD10(-) immunophenotypes. MLL-AF4 is known to be the most frequent fusion transcript, but the exact frequencies of MLL aberrations in CD10(-) adult BCP-ALL are unknown. We present a genetic characterization of 184 BCR-ABL(-) CD10(-) adult ALL cases (156 cyIg(-), 28 cyIg(+)) diagnosed between 2001 and 2007 at the central diagnostic laboratory of the GMALL study group. Patient samples were investigated by RT-PCR for MLL-AF4, MLL-ENL, and MLL-AF9 and by long-distance inverse polymerase chain reaction, thus also allowing the identification of unknown MLL fusion partners at the genomic level. MLL-AF4 was detected in 101 (54.9%) and MLL-ENL in 11 (6.0%) cases. In addition, rare MLL fusion genes were found: 2 MLL-TET1 cases, not previously reported in ALL, 1 MLL-AF9, 1 MLL-PTD, a novel MLL-ACTN4, and an MLL-11q23 fusion. Chromosomal breakpoints were determined in all 118 positive cases, revealing 2 major breakpoint cluster regions in the MLL gene. Characteristic features of MLL(+) patients were significantly lower CD10 expression, expression of the NG2 antigen, a higher white blood count at diagnosis, and female sex. Proposals are made for diagnostic assessment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19144982     DOI: 10.1182/blood-2008-10-183483

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  35 in total

1.  MLL-rearranged B lymphoblastic leukemias selectively express the immunoregulatory carbohydrate-binding protein galectin-1.

Authors:  Przemyslaw Juszczynski; Scott J Rodig; Jing Ouyang; Evan O'Donnell; Kunihiko Takeyama; Wojciech Mlynarski; Katarzyna Mycko; Tomasz Szczepanski; Anna Gaworczyk; Andrei Krivtsov; Joerg Faber; Amit U Sinha; Gabriel A Rabinovich; Scott A Armstrong; Jeffery L Kutok; Margaret A Shipp
Journal:  Clin Cancer Res       Date:  2010-03-23       Impact factor: 12.531

2.  First description of the t(10;11)(q22;q23)/MLL-TET1 translocation in a T-cell lymphoblastic lymphoma, with subsequent lineage switch to acute myelomonocytic myeloid leukemia.

Authors:  Antoine Ittel; Eric Jeandidier; Catherine Helias; Nathalie Perrusson; Catherine Humbrecht; Bruno Lioure; Isabelle Mazurier; Caroline Mayeur-Rousse; Amandine Lavaux; Sylvie Thiebault; Felix Lerintiu; Carine Gervais; Laurent Mauvieux
Journal:  Haematologica       Date:  2013-12       Impact factor: 9.941

3.  MLL-TET1 fusion protein promotes immortalization of myeloid progenitor cells and leukemia development.

Authors:  Hyeng-Soo Kim; Seung Hwan Oh; Ju-Heon Kim; Jae-Young Kim; Do-Hyung Kim; Soo-Jin Lee; Sang-Un Choi; Kwon Moo Park; Zae Young Ryoo; Tae Sung Park; Sanggyu Lee
Journal:  Haematologica       Date:  2017-08-10       Impact factor: 9.941

4.  Genomic breakpoints and clinical features of MLL-TET1 rearrangement in acute leukemias.

Authors:  Sang-Guk Lee; Sun Young Cho; Min Jin Kim; Seung Hwan Oh; Eun Hae Cho; Sanggyu Lee; Eun Jung Baek; Jung Hye Choi; Stefan K Bohlander; Laurence Lode; Steven Richebourg; Hwi-Joong Yoon; Rolf Marschalek; Claus Meyer; Tae Sung Park
Journal:  Haematologica       Date:  2012-10-25       Impact factor: 9.941

5.  Molecular characterization and clinical course of MLL-ACTN4 rearrangement in therapy-related hematologic malignancies.

Authors:  John Jeongseok Yang; Tae Sung Park; Seung-Tae Lee; Ja-Young Seo; Seung Hwan Oh; Eun Hae Cho; Thomas Burmeister; Wolf-Dieter Ludwig; Claus Meyer; Rolf Marschalek; Hee-Jin Kim; Sun-Hee Kim
Journal:  Haematologica       Date:  2014-02-21       Impact factor: 9.941

6.  Germline variants in IKZF1, ARID5B, and CEBPE as risk factors for adult-onset acute lymphoblastic leukemia: an analysis from the GMALL study group.

Authors:  Thomas Burmeister; Gesine Bartels; Daniela Gröger; Heiko Trautmann; Stefan Schwartz; Klaus Lenz; Carola Tietze-Bürger; Andreas Viardot; Ralph Wäsch; Heinz-August Horst; Richard Reinhardt; Nicola Gökbuget; Dieter Hoelzer; Michael Kneba; Monika Brüggemann
Journal:  Haematologica       Date:  2014-02       Impact factor: 9.941

7.  Detection of gene rearrangements in targeted clinical next-generation sequencing.

Authors:  Haley J Abel; Hussam Al-Kateb; Catherine E Cottrell; Andrew J Bredemeyer; Colin C Pritchard; Allie H Grossmann; Michelle L Wallander; John D Pfeifer; Christina M Lockwood; Eric J Duncavage
Journal:  J Mol Diagn       Date:  2014-05-09       Impact factor: 5.568

8.  The Impact of DNA Methylation in Hematopoietic Malignancies.

Authors:  Maria Guillamot; Luisa Cimmino; Iannis Aifantis
Journal:  Trends Cancer       Date:  2016-02-01

9.  The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing.

Authors:  Yun Huang; William A Pastor; Yinghua Shen; Mamta Tahiliani; David R Liu; Anjana Rao
Journal:  PLoS One       Date:  2010-01-26       Impact factor: 3.240

Review 10.  The molecular biology of mixed lineage leukemia.

Authors:  Robert K Slany
Journal:  Haematologica       Date:  2009-06-16       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.